The correlation between neuropathology levels and cognitive performance in centenarians
Alzheimer's & Dementia · 2023-11 · 19 (11) · 5036-5047
DOI: 10.1002/alz.13087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 24.04.2023. Verfasst von Meng Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Genomics of Neurodegenerative Diseases and Aging, Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherland…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
INTRODUCTION Neuropathological substrates associated with neurodegeneration occur in brains of the oldest old. How does this affect cognitive performance? METHODS The 100‐plus Study is an ongoing longitudinal cohort study of centenarians who self‐report to be cognitively healthy; post mortem brain donation is optional. In 85 centenarian brains, we explored the correlations between the levels of 11 neuropathological substrates with ante mortem performance on 12 neuropsychological tests. RESULTS Levels of neuropathological substrates varied: we observed levels up to Thal‐amyloid beta phase 5, Braak‐neurofibrillary tangle (NFT) stage V, Consortium to Establish a Registry for Alzheimer's Disease (CERAD)‐neuritic plaque score 3, Thal‐cerebral amyloid angiopathy stage 3, Tar‐DNA binding protein 43 (TDP‐43) stage 3, hippocampal sclerosis stage 1, Braak‐Lewy bodies stage 6, atherosclerosis stage 3, cerebral infarcts stage 1, and cerebral atrophy stage 2. Granulovacuolar degeneration occurred in all centenarians. Some high performers had the highest neuropathology scores. DISCUSSION Only Braak‐NFT stage and limbic‐predominant age‐related TDP‐43 encephalopathy (LATE) pathology associated significantly with performance across multiple cognitive domains. Of all cognitive tests, the clock‐drawing test was particularly sensitive to levels of multiple neuropathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Genomics of Neurodegenerative Diseases and Aging, Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Delft Bioinformatics Lab, Delft Technical University, Van, The Netherlands.
- Department of Neurology, Alzheimer Center Amsterdam, Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department of Molecular and Cellular Neuroscience, Center for Neurogenomics and Cognitive Research, Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department of Pathology, Neuroscience, Amsterdam, The Netherlands.
- Netherlands Institute for Neuroscience, The Netherlands.
Förderung
- ZonMw
Zitieren
APA
Zhang, M., Ganz, A. B., Rohde, S., Lorenz, L., Rozemuller, A. J. M., van Vliet, K., Graat, M., Sikkes, S. A. M., Reinders, M. J. T., Scheltens, P., Hulsman, M., Hoozemans, J. J. M., & Holstege, H. (2023). The correlation between neuropathology levels and cognitive performance in centenarians. Alzheimer's & Dementia, 19(11), 5036-5047. https://doi.org/10.1002/alz.13087
Vancouver
Zhang M, Ganz AB, Rohde S, Lorenz L, Rozemuller AJM, van Vliet K, et al. The correlation between neuropathology levels and cognitive performance in centenarians. Alzheimer's & Dementia. 2023;19(11):5036-5047. doi:10.1002/alz.13087
BibTeX
@article{Zhang2023,
author = {Zhang, Meng and Ganz, Andrea B and Rohde, Susan and Lorenz, Linda and Rozemuller, Annemieke J M and van Vliet, Kimberley and Graat, Marieke and Sikkes, Sietske A M and Reinders, Marcel J T and Scheltens, Philip and Hulsman, Marc and Hoozemans, Jeroen J M and Holstege, Henne},
title = {The correlation between neuropathology levels and cognitive performance in centenarians},
journal = {Alzheimer's & Dementia},
year = {2023},
volume = {19},
number = {11},
pages = {5036--5047},
doi = {10.1002/alz.13087}
}
EUVIMED